Acorda Therapeutics Total Assets 2006-2020 | ACOR

Acorda Therapeutics total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
Acorda Therapeutics Annual Total Assets
(Millions of US $)
2019 $800
2018 $1,300
2017 $1,198
2016 $1,342
2015 $1,111
2014 $1,065
2013 $607
2012 $565
2011 $379
2010 $342
2009 $319
2008 $282
2007 $127
2006 $84
2005 $34
Acorda Therapeutics Quarterly Total Assets
(Millions of US $)
2020-03-31 $754
2019-12-31 $800
2019-09-30 $880
2019-06-30 $1,197
2019-03-31 $1,234
2018-12-31 $1,300
2018-09-30 $1,311
2018-06-30 $1,251
2018-03-31 $1,187
2017-12-31 $1,198
2017-09-30 $1,345
2017-06-30 $1,332
2017-03-31 $1,320
2016-12-31 $1,342
2016-09-30 $1,318
2016-06-30 $1,347
2016-03-31 $1,212
2015-12-31 $1,111
2015-09-30 $1,100
2015-06-30 $1,101
2015-03-31 $1,099
2014-12-31 $1,065
2014-09-30 $973
2014-06-30 $943
2014-03-31 $612
2013-12-31 $607
2013-09-30 $587
2013-06-30 $576
2013-03-31 $565
2012-12-31 $565
2012-09-30 $410
2012-06-30 $403
2012-03-31 $386
2011-12-31 $379
2011-09-30 $351
2011-06-30 $336
2011-03-31 $336
2010-12-31 $342
2010-09-30 $331
2010-06-30 $296
2010-03-31 $318
2009-12-31 $319
2009-09-30 $338
2009-06-30 $368
2009-03-31 $262
2008-12-31 $282
2008-09-30 $298
2008-06-30 $184
2008-03-31 $196
2007-12-31 $127
2007-09-30 $137
2007-06-30 $134
2007-03-31 $68
2006-12-31 $84
2006-09-30 $40
2006-06-30 $44
2006-03-31 $50
2005-12-31 $34
2005-09-30 $0
2005-06-30 $0
2005-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.031B $0.192B
Acorda Therapeutics, Inc. is a biotechnology company developing and commercializing neurology therapies for Parkinson's disease, migraine and multiple sclerosis. Acorda has a pipeline of novel neurological therapies addressing a range of disorders, including Parkinson's disease and multiple sclerosis. Acorda markets three FDA-approved therapies, including AMPYRA? (dalfampridine) Extended Release Tablets, 10 mg.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $142.669B 15.50
Bristol Myers Squibb (BMY) United States $134.562B 11.24
CSL (CSLLY) Australia $91.768B 0.00
Gilead Sciences (GILD) United States $88.910B 12.79
Vertex Pharmaceuticals (VRTX) United States $71.813B 40.07
Regeneron Pharmaceuticals (REGN) United States $71.339B 27.50
Illumina (ILMN) United States $57.871B 59.47
Biogen (BIIB) United States $43.707B 7.48
Moderna (MRNA) United States $29.126B 0.00
Seattle Genetics (SGEN) United States $28.722B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $24.736B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.061B 9.61
Genmab (GMAB) Denmark $23.061B 18.97
Genmab (GNMSF) Denmark $21.833B 64.82
Incyte (INCY) United States $21.726B 0.00
BioMarin Pharmaceutical (BMRN) United States $21.670B 157.67
BeiGene (BGNE) Cayman Islands $19.895B 0.00
BioNTech SE (BNTX) Germany $18.818B 0.00
Alnylam Pharmaceuticals (ALNY) United States $17.622B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.565B 70.47
Exact Sciences (EXAS) United States $13.957B 0.00
Galapagos (GLPG) Belgium $12.394B 36.46
Sarepta Therapeutics (SRPT) United States $12.223B 0.00
Horizon Therapeutics Public (HZNP) Ireland $11.788B 29.01
ARGENX SE-ADR (ARGX) Netherlands $10.887B 0.00
QIAGEN (QGEN) Netherlands $10.816B 31.45
Bio-Techne Corp (TECH) United States $10.584B 73.25
Immunomedics (IMMU) United States $10.192B 0.00
Novavax (NVAX) United States $9.109B 0.00
Repligen (RGEN) United States $8.219B 130.45
Guardant Health (GH) United States $7.994B 0.00
Ascendis Pharma (ASND) Denmark $7.808B 0.00
Exelixis (EXEL) United States $7.191B 25.22
ACADIA Pharmaceuticals (ACAD) United States $6.783B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.636B 205.59
Emergent Biosolutions (EBS) United States $6.490B 25.71
SWEDISH ORP BIO (BIOVF) Sweden $6.351B 15.80
Vir Biotechnology (VIR) United States $5.966B 0.00
Acceleron Pharma (XLRN) United States $5.715B 0.00
Mirati Therapeutics (MRTX) United States $5.414B 0.00
Adaptive Biotechnologies (ADPT) United States $5.160B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.100B 0.00
Reata Pharmaceuticals (RETA) United States $4.947B 0.00
Zai Lab (ZLAB) China $4.648B 0.00
MyoKardia (MYOK) United States $4.575B 0.00
MorphoSys AG (MOR) Germany $4.516B 35.03
NeoGenomics (NEO) United States $4.286B 1293.67
China Biologic Products (CBPO) China $4.196B 23.33
Global Blood Therapeutics (GBT) United States $4.190B 0.00
Blueprint Medicines (BPMC) United States $4.066B 0.00
Halozyme Therapeutics (HALO) United States $3.886B 0.00
Amicus Therapeutics (FOLD) United States $3.811B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.791B 0.00
Bluebird Bio (BLUE) United States $3.475B 0.00
Inovio Pharmaceuticals (INO) United States $3.212B 0.00
Arena Pharmaceuticals (ARNA) United States $3.202B 0.00
Alkermes (ALKS) Ireland $2.974B 62.33
Principia Biopharma (PRNB) United States $2.831B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.711B 0.00
Amarin (AMRN) Ireland $2.710B 0.00
Insmed (INSM) United States $2.702B 0.00
Sorrento Therapeutics (SRNE) United States $2.692B 0.00
Twist Bioscience (TWST) United States $2.553B 0.00
Fate Therapeutics (FATE) United States $2.534B 0.00
Denali Therapeutics (DNLI) United States $2.471B 0.00
PHARMA MAR SA (PHMMF) Spain $1.922B 0.00
Ligand Pharmaceuticals (LGND) United States $1.893B 64.09
UniQure (QURE) Netherlands $1.878B 0.00
Viela Bio (VIE) United States $1.839B 0.00
Mesoblast (MESO) Australia $1.805B 0.00
Editas Medicine (EDIT) United States $1.761B 0.00
I-Mab (IMAB) China $1.753B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.657B 0.00
Eidos Therapeutics (EIDX) United States $1.620B 0.00
Sangamo Therapeutics (SGMO) United States $1.612B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.567B 0.00
Zymeworks (ZYME) Canada $1.429B 0.00
Adverum Biotechnologies (ADVM) United States $1.416B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.374B 0.00
Revance Therapeutics (RVNC) United States $1.369B 0.00
Zealand Pharma (ZEAL) Denmark $1.366B 0.00
Mersana Therapeutics (MRSN) United States $1.361B 0.00
Intra-Cellular Therapies (ITCI) United States $1.354B 0.00
NGM Biopharmaceuticals (NGM) United States $1.310B 0.00
Cytokineticsorporated (CYTK) United States $1.310B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
Coherus BioSciences (CHRS) United States $1.269B 8.86
REGENXBIO (RGNX) United States $1.257B 0.00
Epizyme (EPZM) United States $1.243B 0.00
Arvinas (ARVN) United States $1.193B 0.00
Alector (ALEC) United States $1.187B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.161B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.157B 0.00
Akcea Therapeutics (AKCA) United States $1.131B 0.00
Alcobra (ARCT) United States $1.126B 0.00
Compugen (CGEN) Israel $1.100B 0.00
NantKwest (NK) United States $1.090B 0.00
VBI Vaccines (VBIV) United States $1.013B 0.00
Intellia Therapeutics (NTLA) United States $1.007B 0.00
Beam Therapeutics (BEAM) United States $0.999B 0.00
Retrophin (RTRX) United States $0.987B 0.00
Arcus Biosciences (RCUS) United States $0.967B 0.00
Heska (HSKA) United States $0.939B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.932B 40.04
Athenex (ATNX) United States $0.917B 0.00
Myriad Genetics (MYGN) United States $0.915B 47.19
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.873B 0.00
Dynavax Technologies (DVAX) United States $0.831B 0.00
Cara Therapeutics (CARA) United States $0.806B 0.00
Intrexon (PGEN) United States $0.796B 0.00
Vericel (VCEL) United States $0.759B 140.17
Pharming Group (PHGUF) Netherlands $0.739B 16.86
Cellectis S.A (CLLS) France $0.733B 0.00
Codexis (CDXS) United States $0.723B 0.00
Castle Biosciences (CSTL) United States $0.712B 0.00
Morphic Holding (MORF) United States $0.705B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.684B 0.00
Frequency Therapeutics (FREQ) United States $0.673B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.661B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
MiMedx (MDXG) United States $0.629B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Kadmon Holdings (KDMN) United States $0.592B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.591B 5.06
Agenus (AGEN) United States $0.578B 0.00
Cue Biopharma (CUE) United States $0.546B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.537B 0.00
Athersys (ATHX) United States $0.522B 0.00
IBio (IBIO) United States $0.520B 0.00
Kala Pharmaceuticals (KALA) United States $0.509B 0.00
Prothena (PRTA) Ireland $0.501B 0.00
Syros Pharmaceuticals (SYRS) United States $0.496B 0.00
AnaptysBio (ANAB) United States $0.493B 0.00
MeiraGTx Holdings (MGTX) United States $0.490B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.489B 0.00
Clovis Oncology (CLVS) United States $0.481B 0.00
AC Immune SA (ACIU) Switzerland $0.476B 0.00
Innate Pharma S.A (IPHA) France $0.475B 0.00
Anika Therapeutics (ANIK) United States $0.471B 20.58
UROGEN PHARMA (URGN) United States $0.464B 0.00
Cel-Sci (CVM) United States $0.453B 0.00
Protagonist Therapeutics (PTGX) United States $0.443B 0.00
BioDelivery Sciences (BDSI) United States $0.427B 22.42
Puma Biotechnology (PBYI) United States $0.425B 0.00
Avid Bioservices (CDMO) United States $0.424B 0.00
Prometic Life Sciences (LMNL) Canada $0.416B 0.00
Kamada (KMDA) Israel $0.394B 16.41
Xenon Pharmaceuticals (XENE) Canada $0.393B 0.00
PDL BioPharma (PDLI) United States $0.392B 344.00
Aquinox Pharmaceuticals (NLTX) United States $0.392B 0.00
Merus (MRUS) Netherlands $0.391B 0.00
ANI Pharmaceuticals (ANIP) United States $0.380B 7.40
Scholar Rock Holding (SRRK) United States $0.379B 0.00
Albireo Pharma (ALBO) United States $0.371B 0.00
MannKind (MNKD) United States $0.354B 0.00
Geron (GERN) United States $0.352B 0.00
Precision BioSciences (DTIL) United States $0.350B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.343B 0.00
CytomX Therapeutics (CTMX) United States $0.334B 0.00
WAVE Life Sciences (WVE) Singapore $0.321B 0.00
Seres Therapeutics (MCRB) United States $0.320B 0.00
ChromaDex (CDXC) United States $0.314B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.305B 0.00
Trevena (TRVN) United States $0.300B 0.00
Menlo Therapeutics (MNLO) United States $0.297B 0.00
OSMOTICA PHARM (OSMT) United States $0.293B 0.00
ADMA Biologics Inc (ADMA) United States $0.291B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.289B 0.00
Affimed (AFMD) Germany $0.285B 0.00
Starpharma Holdings (SPHRY) Australia $0.276B 0.00
Spero Therapeutics (SPRO) United States $0.275B 0.00
Cellular Biomedicine (CBMG) United States $0.263B 0.00
NextCure (NXTC) United States $0.261B 0.00
Northwest Biotherapeutics (NWBO) United States $0.260B 0.00
Pluristem Therapeutics (PSTI) Israel $0.259B 0.00
Arbutus Biopharma (ABUS) United States $0.259B 0.00
DBV Technologies S.A (DBVT) France $0.257B 0.00
Celldex Therapeutics (CLDX) United States $0.252B 0.00
Pfenex (PFNX) United States $0.251B 0.00
Dyadic (DYAI) United States $0.247B 0.00
Abeona Therapeutics (ABEO) United States $0.244B 0.00
Verastem (VSTM) United States $0.241B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.235B 0.00
Fortress Biotech (FBIO) United States $0.232B 0.00
Selecta Biosciences (SELB) United States $0.229B 0.00
HOOKIPA Pharma (HOOK) United States $0.225B 0.00
Five Prime Therapeutics (FPRX) United States $0.222B 0.00
IVERIC Bio (ISEE) United States $0.221B 0.00
Strongbridge Biopharma (SBBP) United States $0.220B 0.00
Aduro Biotech (ADRO) United States $0.216B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.210B 9.80
Exicure (XCUR) United States $0.203B 0.00
GENFIT S.A (GNFT) France $0.200B 0.00
Sutro Biopharma (STRO) United States $0.197B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.195B 0.00
Aptinyx (APTX) United States $0.189B 0.00
Theratechnologies (THTX) Canada $0.188B 0.00
XOMA (XOMA) United States $0.187B 0.00
POXEL SA FRANCE (PXXLF) France $0.177B 0.00
Aytu Bioscience (AYTU) United States $0.172B 0.00
Cerecor (CERC) United States $0.171B 0.00
VTv Therapeutics (VTVT) United States $0.169B 0.00
Bellus Health (BLU) Canada $0.164B 0.00
Liquidia Technologies (LQDA) United States $0.161B 0.00
Cidara Therapeutics (CDTX) United States $0.160B 0.00
TELA Bio (TELA) United States $0.151B 0.00
VolitionRX (VNRX) United States $0.146B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.144B 0.00
Eton Pharmaceuticals (ETON) United States $0.142B 0.00
Celyad SA (CYAD) Belgium $0.141B 0.00
Kindred Biosciences (KIN) United States $0.140B 0.00
Cyclerion Therapeutics (CYCN) United States $0.139B 0.00
Applied Genetic Technologies (AGTC) United States $0.138B 0.00
Palatin Technologies (PTN) United States $0.131B 3.37
Lineage Cell Therapeutics (LCTX) United States $0.127B 0.00
Checkpoint Therapeutics (CKPT) United States $0.126B 0.00
Biofrontera AG (BFRA) Germany $0.126B 0.00
Cardiff Oncology (CRDF) United States $0.124B 0.00
Gritstone Oncology (GRTS) United States $0.123B 0.00
Oncobiologics (OTLK) United States $0.121B 0.00
Cocrystal Pharma (COCP) United States $0.120B 0.00
Orgenesis (ORGS) United States $0.120B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
PHASEBIO PHARMA (PHAS) United States $0.118B 0.00
Windtree Therapeutics (WINT) United States $0.118B 0.00
Protalix BioTherapeutics (PLX) Israel $0.117B 0.00
SESEN BIO, INC (SESN) United States $0.116B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.115B 0.00
Lumos Pharma (LUMO) United States $0.115B 0.00
AquaBounty Technologies (AQB) United States $0.111B 0.00
Vaccinex (VCNX) United States $0.111B 0.00
CorMedix Inc (CRMD) United States $0.111B 0.00
AIT Therapeutics (XAIR) United States $0.104B 0.00
ARAVIVE, INC (ARAV) United States $0.094B 0.00
Organovo Holdings (ONVO) United States $0.094B 0.00
Antibe Therapeutics (ATBPF) Canada $0.093B 0.00
Proteostasis Therapeutics (PTI) United States $0.092B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.091B 0.00
Unum Therapeutics (UMRX) United States $0.089B 0.00
DiaMedica Therapeutics (DMAC) United States $0.083B 0.00
Adocia (ADOCY) France $0.080B 0.00
Clearside Biomedical (CLSD) United States $0.079B 0.00
Ecology Coatings (ABVC) United States $0.079B 0.00
Emmaus Life Sciences (EMMA) United States $0.076B 0.00
Synlogic (SYBX) United States $0.073B 0.00
Stealth BioTherapeutics (MITO) United States $0.073B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.071B 0.00
Idera Pharmaceuticals (IDRA) United States $0.069B 0.00
AnPac Bio-Medical Science (ANPC) China $0.068B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.068B 0.00
Bionano Genomics (BNGO) United States $0.065B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.064B 0.00
Soligenix (SNGX) United States $0.063B 0.00
Edesa Biotech (EDSA) Canada $0.063B 0.00
Happiness Biotech Group (HAPP) China $0.061B 0.00
Signal Genetics (MGEN) United States $0.061B 0.00
IMMURON (IMRN) Australia $0.057B 0.00
Vascular Biogenics (VBLT) Israel $0.055B 0.00
CollPlant Holdings (CLGN) Israel $0.054B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.054B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.052B 0.00
Prima BioMed (IMMP) Australia $0.051B 0.00
Prana Biotechnology (ATHE) Australia $0.050B 0.00
Apricus Biosciences (SEEL) United States $0.049B 0.00
Curis (CRIS) United States $0.048B 0.00
AmpliPhi Biosciences (ARMP) United States $0.042B 0.00
Celsion (CLSN) United States $0.042B 0.00
Spherix (AIKI) United States $0.038B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
Advaxis (ADXS) United States $0.035B 0.00
Genetic Technologies (GENE) Australia $0.035B 0.00
Cesca Therapeutics (THMO) United States $0.034B 0.00
OvaScience (MLND) United States $0.034B 0.00
Chanticleer Holdings (SONN) United States $0.033B 0.00
Pulmatrix (PULM) United States $0.033B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.032B 0.00
Forte Biosciences (FBRX) United States $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.030B 0.00
Evogene (EVGN) Israel $0.030B 0.00
Cleveland BioLabs (CBLI) United States $0.028B 0.00
Novogen (KZIA) Australia $0.028B 0.00
Alimera Sciences (ALIM) United States $0.027B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.024B 0.00
BioPharmX (TMBR) United States $0.022B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
BioCardia (BCDA) United States $0.018B 0.00
Neuralstem (SNCA) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00